MidWestOne Financial Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,791
Closed -$275K 307
2025
Q3
$275K Buy
+1,791
New +$271K 0.03% 261

Other funds holding AZN

MidWestOne Financial Group's AZN Position: Q4 2025 in Review

MidWestOne Financial Group sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 1,791 shares — an estimated $275K sold.

MidWestOne Financial Group first reported a position in AZN in Q3 2025 and held it in 1 quarter. The position peaked at $275K in Q3 2025. 1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • MidWestOne Financial Group reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • MidWestOne Financial Group sold 1,791 AstraZeneca shares in Q4 2025, an estimated $275K.
  • MidWestOne Financial Group first reported a position in AstraZeneca in Q3 2025 and held it in 1 quarter.
  • MidWestOne Financial Group's AstraZeneca position peaked at $275K in Q3 2025.
  • 1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on MidWestOne Financial Group's 13F filing for Q4 2025, filed 12 Feb 2026.